SCHEMBL10039706

SCHEMBL10039706

C=CC(=C)Cc1n[nH]c(=O)c2ccccc12

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ PRMT5 O14744 1/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ POLB P06746 2/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ AR P10275 8/20 0.53
▸ PARP1 P09874 1/20 0.53
▸ MEN1 O00255 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10054617 0.80 LMNA (0.60) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL5717747 0.78 LMNA (1.00) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL30151141 0.78 LMNA (1.00) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL4931969 0.76 LMNA (0.73) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL17213420 0.75 SMN1; SMN2 (0.73) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL4817305 0.75 PRMT5 (0.68) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL19881880 0.74 LMNA (0.53) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL9328808 0.73 SMN1; SMN2 (1.00) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL8559783 0.72 PRMT5 (0.64) LMNASMN1; SMN2PRMT5ALDH1A1POLB
SCHEMBL23909125 0.72 PRMT5 (0.68) LMNASMN1; SMN2PRMT5ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019430-A1 PHTHALAZINONE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 — — WO disclosed
Send feedback